Replacement hormone approved for treatment of hypoparathyroidism Approval of the recombinant human parathyroid hormone rhPTH(1-84), currently an expensive drug, for treatment of hypoparathyroidism has stimulated research into new treatment modalities and development of PTH analogues.
Frail patients benefit more from valve replacement than nonfrail peers Researchers comparing physical and mental health, well-being, and quality of life between frail and nonfrail patients with aortic valve stenosis before and after valve replacement surgery found that individuals deemed frail before surgery demonstrated greater benefit.
Posterior fossa biopsy aids tissue diagnosis safety A study of posterior fossa biopsies performed at Mayo Clinic from 1996 to 2009 indicates that, in carefully selected patients with inflammatory brain diseases, the posterior fossa is appropriate to cerebellar and brainstem parenchymal biopsy.
Mayo Clinic Pediatric Days 2017 Oct. 8-10, 2017, in Chicago
This course focuses on reviews of commonly encountered clinical scenarios and their incorporation into daily practice, evaluation and management of patients based on in-depth interviews and studies, and effective clinical strategies for diagnosing and managing an array of challenging problems.
Tuberculosis Clinical Intensive — Des Moines, Iowa 2017 Oct. 16, 2017, in Des Moines, Iowa
This course covers tuberculosis epidemiology, transmission, diagnosis and treatment, plus medication review and case management. The course is free of charge.
Mayo Clinic Healthy Living Sept. 16, Oct. 21, and Nov. 18, 2017, in Washington, D.C.
Mayo experts explore topics that support the importance of a healthy lifestyle at home and on the road: Resilient You, Physician Wellness, and Eat Well, Live Well.
A Multidisciplinary Approach to Genitourinary Cancers Mayo specialists discuss the benefits of robotic-assisted surgery for patients with testicular cancer, trimodality therapy for patients with bladder cancer and multidisciplinary care for patients with kidney cancer.